Characterization of Type-2 Cytokine-Producing NK Cells
Characterization of Type-2 Cytokine-Producing NK Cells
批准号:
7860305
负责人:
Kerry S Campbell
金额:
$27.61万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-05 至 2012-05-31
关键词:
AddressAllergensAllergicAllergic DiseaseAllergic inflammationAsthmaBindingBiologicalBiologyCatalogingCatalogsCell ProliferationCell physiologyCellsCharacteristicsChemotaxisClinicalCommunicable DiseasesDataDevelopmentDiseaseEquilibriumExposure toExtrinsic asthmaFutureGastrointestinal tract structureGene ExpressionGenesGeneticGoalsHealthHumanHuman VolunteersImmuneImmune responseImmunosuppressionIndividualInfectionInflammatoryInflammatory ResponseInterleukin-13Interleukin-4Interleukin-5IntestinesIrrigationKnowledgeLeukocytesLocationLungMediatingModelingMolecular TargetMusNatural Killer CellsPathogenesisPhenotypePlayPopulationProcessProductionProstaglandin D2ProstaglandinsPublic HealthRecruitment ActivityRegulationReportingRoleSignal TransductionSiteSurfaceTestingTh2 CellsTimeType - attributeWorkallergic responsebasecell typechemokinecytokinecytotoxicityfMet-Leu-Phe receptorhuman subjectimprovedin vivomacrophagemast cellmicrobialmouse modelmucosal sitenovelpathogenprostaglandin D receptorpublic health relevancereceptorrespiratoryresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Allergic immune responses are biased toward the production of type-2 cytokines. We have identified new surface markers of a small subset of human natural killer (NK) cells that produce the type-2 cytokines, IL-4 and IL-13. In addition, we have shown that these type-2 NK cells are enriched in the lungs of atopic human subjects in response to allergenic challenge. Therefore, our data suggest that these cells may contribute to the inflammatory response at sites of allergenic insult, such as mucosal surfaces of the lung and gastrointestinal tract. Our discovery of better surface markers to delineate these cells allows us to better purify them and define their functions. In this application, we propose exploratory studies to significantly improve our understanding of the biology of type-2 NK cells. Specifically, we will 1) catalog receptors on the human type-2 NK cells and test their impacts on biological responses, and 2) use our knowledge in humans to characterize the type-2 NK cells in mice and test whether they can also respond to allergenic challenge in a mouse model of asthma. The findings will fill significant gaps in our understanding of environmental signals that regulate the functions of type-2 NK cells, and establish a mouse model for studying their in vivo functions. Improved understanding of these biological parameters will allow us to establish the roles of type-2 NK cells in the pathogenesis of localized allergic responses and infections, particularly in the respiratory and intestinal tracts. Future studies, based upon our findings, will be able to identify molecular targets to manipulate the functions of type-2 NK cells to improve human health. PUBLIC HEALTH RELEVANCE: to Public Health Natural killer (NK) cells are normal white blood cells that can stimulate innate immune responses. We have recently discovered surface markers to define a small subset of NK cells that can enter the lungs of human volunteers after exposure to an allergen. These cells are unique, since they can produce soluble factors that may contribute to allergic inflammation, and therefore, we will further study these cells in humans and mice to establishing their role in human health and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
-
批准号:10319570
-
项目类别:
-
资助金额:$50.65万
-
财政年份:2020
-
负责人:Kerry S Campbell
-
依托单位:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
-
批准号:10544158
-
项目类别:
-
资助金额:$50.26万
-
财政年份:2020
-
负责人:Kerry S Campbell
-
依托单位:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
-
批准号:10078249
-
项目类别:
-
资助金额:$51.02万
-
财政年份:2020
-
负责人:Kerry S Campbell
-
依托单位:
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
-
批准号:9038558
-
项目类别:
-
资助金额:$66.25万
-
财政年份:2016
-
负责人:Kerry S Campbell
-
依托单位:
Characterization of Type-2 Cytokine-Producing NK Cells
-
批准号:8073248
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2010
-
负责人:Kerry S Campbell
-
依托单位:
Characterization of Type-2 Cytokine-Producing NK Cells
-
批准号:7707072
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2009
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:7332209
-
项目类别:
-
资助金额:$26.28万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:6860141
-
项目类别:
-
资助金额:$27.78万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:7168804
-
项目类别:
-
资助金额:$26.28万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:7013613
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:6724624
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
NEGATIVE SIGNALLING BY KILLER CELL INHIBITORY RECEPTORS
-
批准号:6194275
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:8211081
-
项目类别:
-
资助金额:$30.37万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:7779658
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
NEGATIVE SIGNALLING BY KILLER CELL INHIBITORY RECEPTORS
-
批准号:6377620
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
NEGATIVE SIGNALLING BY KILLER CELL INHIBITORY RECEPTORS
-
批准号:6514230
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:8606416
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:8433503
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Negative Signalling by Killer Ig-like Receptors
-
批准号:7393731
-
项目类别:
-
资助金额:$28.84万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Negative Signalling by Killer Ig-like Receptors
-
批准号:7208993
-
项目类别:
-
资助金额:$28.84万
-
财政年份:1999
-
负责人:Kerry S Campbell
-
依托单位:
海外基金